Literature DB >> 20177959

The IL-17 family cytokines in immunity and disease.

Rajita Pappu1, Vladimir Ramirez-Carrozzi, Naruhisa Ota, Wenjun Ouyang, Yan Hu.   

Abstract

INTRODUCTION: Accumulating evidence suggests that the interleukin (IL)-17 cytokines are major players in the immune response to foreign pathogens. In addition, the pathogeneses of a number of inflammatory diseases have been linked to uncontrolled expression of these cytokine pathways. DISCUSSION: Genetic and biochemical analyses have elucidated the cellular and molecular events triggered by these proteins during an inflammatory response. While significant efforts have been placed on understanding the functions of IL-17A, IL-17F, and IL-17E, the significance of the other family members, IL-17B-D, in inflammation remains to be determined.
CONCLUSION: This review will focus on the cellular sources, target cell/receptors that are utilized by these cytokines to control pathogenesis, and the therapeutic potential of targeting these pathways to treat inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20177959     DOI: 10.1007/s10875-010-9369-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  120 in total

1.  Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.

Authors:  Kyle I Happel; Mingquan Zheng; Erana Young; Lee J Quinton; Euan Lockhart; Alistair J Ramsay; Judd E Shellito; Jill R Schurr; Gregory J Bagby; Steve Nelson; Jay K Kolls
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

2.  Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice.

Authors:  G Pan; D French; W Mao; M Maruoka; P Risser; J Lee; J Foster; S Aggarwal; K Nicholes; S Guillet; P Schow; A L Gurney
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

3.  Expression of IL-17B in neurons and evaluation of its possible role in the chromosome 5q-linked form of Charcot-Marie-Tooth disease.

Authors:  Emma E Moore; Scott Presnell; Ursula Garrigues; Angele Guilbot; Eric LeGuern; Deborah Smith; Lena Yao; Theodore E Whitmore; Teresa Gilbert; Theo D Palmer; Philip J Horner; Rolf E Kuestner
Journal:  Neuromuscul Disord       Date:  2002-02       Impact factor: 4.296

4.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

5.  Differential regulation of the IL-17 receptor by gammac cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway.

Authors:  Matthew J Lindemann; Zihua Hu; Marta Benczik; Kathleen D Liu; Sarah L Gaffen
Journal:  J Biol Chem       Date:  2008-03-17       Impact factor: 5.157

6.  Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors.

Authors:  M A Antonysamy; W C Fanslow; F Fu; W Li; S Qian; A B Troutt; A W Thomson
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

7.  Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities.

Authors:  Erika A Rickel; Lori A Siegel; Bo-Rin Park Yoon; James B Rottman; David G Kugler; David A Swart; Penny M Anders; Joel E Tocker; Michael R Comeau; Alison L Budelsky
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

8.  New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25.

Authors:  Stephen D Hurst; Tony Muchamuel; Daniel M Gorman; Jonathan M Gilbert; Theresa Clifford; Sylvia Kwan; Satish Menon; Brian Seymour; Craig Jackson; Ted T Kung; Joan K Brieland; Sandra M Zurawski; Richard W Chapman; Gerard Zurawski; Robert L Coffman
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

9.  Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation.

Authors:  Kei Ikeda; Hiroshi Nakajima; Kotaro Suzuki; Shin-ichiro Kagami; Koichi Hirose; Akira Suto; Yasushi Saito; Itsuo Iwamoto
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113

10.  Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.

Authors:  Roberta Caruso; Massimiliano Sarra; Carmine Stolfi; Angelamaria Rizzo; Daniele Fina; Massimo Claudio Fantini; Francesco Pallone; Thomas T MacDonald; Giovanni Monteleone
Journal:  Gastroenterology       Date:  2009-06       Impact factor: 22.682

View more
  38 in total

1.  Genetic polymorphisms of interleukin 17A and interleukin 17F and their association with inflammatory bowel disease in a Chinese Han population.

Authors:  Xiaofei Zhang; Pengli Yu; Ying Wang; Wenyu Jiang; Fangcheng Shen; Yamin Wang; Huiming Tu; Xiaozhong Yang; Ruihua Shi; Hongjie Zhang
Journal:  Inflamm Res       Date:  2013-05-08       Impact factor: 4.575

2.  Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesions.

Authors:  Tricia L Peters; Kenneth L McClain; Carl E Allen
Journal:  Mol Ther       Date:  2011-06-07       Impact factor: 11.454

3.  Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection.

Authors:  Guanfang Shi; David J Field; Kyung-ae Ko; Sara Ture; Kalyan Srivastava; Scott Levy; M Anna Kowalska; Mortimer Poncz; Deborah J Fowell; Craig N Morrell
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

4.  Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL/lpr mice by inhibiting expression of Ca(2+)/calmodulin-dependent protein kinase-4.

Authors:  Bingjie Shui; Weibiao Xia; Chengping Wen; Xinghong Ding
Journal:  J Nat Med       Date:  2015-03-28       Impact factor: 2.343

5.  Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist.

Authors:  Robert J Cherney; Lyndon A M Cornelius; Anurag Srivastava; Carolyn A Weigelt; David Marcoux; James J-W Duan; Qing Shi; Douglas G Batt; Qingjie Liu; Shiuhang Yip; Dauh-Rurng Wu; Max Ruzanov; John Sack; Javed Khan; Jinhong Wang; Melissa Yarde; Mary Ellen Cvijic; Arvind Mathur; Sha Li; David Shuster; Purnima Khandelwal; Virna Borowski; Jenny Xie; Mary Obermeier; Aberra Fura; Kevin Stefanski; Georgia Cornelius; Joseph A Tino; John E Macor; Luisa Salter-Cid; Rex Denton; Qihong Zhao; Percy H Carter; T G Murali Dhar
Journal:  ACS Med Chem Lett       Date:  2020-03-31       Impact factor: 4.345

6.  Regulation of IL-17A and implications for TGF-β1 comodulation of airway smooth muscle remodeling in severe asthma.

Authors:  Jon M Evasovic; Cherie A Singer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-02-27       Impact factor: 5.464

7.  Involvement of interleukin-17A in pancreatic damage in rat experimental acute necrotizing pancreatitis.

Authors:  Jianbo Ni; Guoyong Hu; Jie Xiong; Jie Shen; Jiaqing Shen; Lijuan Yang; Maochun Tang; Yan Zhao; Guojian Ying; Ge Yu; Yanling Hu; Miao Xing; Rong Wan; Xingpeng Wang
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

8.  Diverse cytokine profile from mesenteric lymph node cells of cull cows severely affected with Johne's disease.

Authors:  Dairu Shu; Supatsak Subharat; D Neil Wedlock; Dongwen Luo; Geoffrey W de Lisle; Bryce M Buddle
Journal:  Clin Vaccine Immunol       Date:  2011-07-27

9.  Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential.

Authors:  Herbert Kellner
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-06       Impact factor: 5.346

10.  Distinctive expression pattern of interleukin-17 cytokine family members in colorectal cancer.

Authors:  Ahmed Al-Samadi; Shirin Moossavi; Abdelhakim Salem; Masoud Sotoudeh; Sarianna M Tuovinen; Yrjö T Konttinen; Tuula Salo; Faraz Bishehsari
Journal:  Tumour Biol       Date:  2015-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.